The U.S. Department of Defense (DoD) recently launched the MD5 National Security Technology Accelerator to create solutions for humanitarian issues…
Soligenix, Inc. was recently invited to the annual Radiation Research Society meeting to present preliminary results from its gastrointestinal acute…
According to a recent clinical trial conducted by the National Institute of Allergy and Infectious Diseases (NIAID), ZMapp was found…
A bipartisan coalition of U.S. senators recently urged the Obama administration in a letter to clarify their position on the…
A group of international vaccine experts recently shared a series of requirements for the development of a safe and effective…
Soligenix, Inc. was invited to the National Organization for Rare Disorders’ (NORD) Rare Diseases and Orphan Products Breakthrough Summit on…
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response recently entered into…
Emergent BioSolutions, Inc., released an update on Friday of the status of its 2011 procurement contract for BioThrax with the…
A team of researchers from the National Institutes of Health and other research institutions recently developed a DNA vaccine to…
The U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) recently…
Emergent BioSolutions, Inc., announced on Friday that it has signed a multi-year contract for the advanced development and delivery of…
Aeolus Pharmaceuticals, Inc., published additional data demonstrating the efficacy of AEOL 10150 as a medical countermeasure to sulfur mustard gas…
Elusys Therapeutics, Inc., published data on Thursday on more than 450 healthy adult subjects from five clinical trials used to…
Secretary General of INTERPOL Jürgen Stock recently spoke at a meeting of security ministers from countries in the Central African…
The Centers for Medical and Medicaid Services (CMS) finalized a rule on Thursday to establish consistent emergency preparedness requirements for…
BioCryst Pharmaceuticals, Inc., released positive results on Wednesday from a proof-of-concept study of its broad spectrum antiviral, BCX4430, for the…
Aeolus Pharmaceuticals, Inc., recently released data confirming the efficacy of AEOL 10150 as a medical countermeasure against sulfur mustard gas…
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) recently…
The U.S. government has become “somewhat complacent” in preparing for potential bioterrorist attacks and needs to implement a national biodefense…
Legislation that would require the United States to develop a national biodefense strategy to help prevent and respond to a…
A research team at the National Center for Advancing Translational Sciences (NCATS) recently identified compounds that could be used to…
Researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID) recently developed a novel system to grow norovirus…
The U.S. Food and Drug Administration (FDA) recently approved Emergent BioSolutions, Inc.’s supplemental Biologics License Application (sBLA) for the manufacture…
The U.S. Centers for Disease Control and Prevention (CDC) exercised a contract option with Emergent BioSolutions, Inc., on Tuesday valued…
ClinicalRM recently expanded access protocol with ZMapp, an investigational treatment for Ebola virus disease (EVD) in Africa and the United…
SIGA Technologies, Inc., received approval on Tuesday from its data safety monitoring board (DSMB) to complete enrollment in the second…
U.S. Sen. Marco Rubio (R-FL) renewed his push on Thursday to reintroduce legislation that would provide additional protections from the…
Altimmune, Inc., and the Biomedical Advanced Research and Development Authority (BARDA) are set to advance the first clinical trial later…
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded…
Bavarian Nordic A/S initiated its Phase 1 clinical trial of MVA-BN YF on Tuesday to protect against yellow fever virus.…
U.S. Sen. Marco Rubio (R-FL) on Wednesday urged President Obama to use unspent funds from other programs to combat the…
The Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID) provided additional…
The Alliance for Biosecurity applauded the House Energy and Commerce Committee on Friday for passing the Strengthening Public Health Emergency…
Soligenix released positive preliminary proof-of-concept results on Monday from its collaboration with Axel Lehrer to develop a heat-stable subunit Ebola…
The House Energy and Commerce Committee passed a bill on Thursday introduced by U.S. Reps. Susan Brooks (R-IN) and Anna…
This website uses cookies.